Sequential Vacc-4x and romidepsin during combination antiretroviral therapy (cART): Immune responses to Vacc-4x regions on p24 and changes in HIV reservoirs

Publikation: Forskning - peer reviewTidsskriftartikel

DOI

  • G Tapia
    G TapiaCentre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, BH10-527, CH-1011 Lausanne, Switzerland.
  • J F Højen
  • M Ökvist
    M ÖkvistBionor Pharma AS, P.O.Box 1477 Vika, NO-0116 Oslo, Norway.
  • R Olesen
  • S Leth
  • S K Nissen
  • D J VanBelzen
    D J VanBelzenUniversity of, Philadelphia, Pennsylvania 19104, USA.
  • U O'Doherty
    U O'DohertyUniversity of, Philadelphia, Pennsylvania 19104, USA.
  • A Mørk
    A MørkBionor Pharma AS, P.O.Box 1477 Vika, NO-0116 Oslo, Norway.
  • K Krogsgaard
    K KrogsgaardBionor Pharma AS, P.O.Box 1477 Vika, NO-0116 Oslo, Norway.
  • O S Søgaard
  • L Østergaard
  • M Tolstrup
  • G Pantaleo
    G PantaleoCentre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, BH10-527, CH-1011 Lausanne, Switzerland.
  • M A Sommerfelt
    M A SommerfeltBionor Pharma AS, P.O.Box 1477 Vika, NO-0116 Oslo, Norway. Electronic address: ms@bionorpharma.com.
OriginalsprogEngelsk
TidsskriftThe Journal of infection
ISSN0163-4453
DOI
StatusUdgivet - dec. 2017

Se relationer på Aarhus Universitet Citationsformater

ID: 118008840